FilingIndex
DEF 14AThe Ballot

Kalaris Therapeutics, Inc. files DEF 14A

Filed Apr 12, 2021 · 5y ago · Accession 0001193125-21-113152

Plain English

Proxy statement — executive pay, board nominees, and shareholder votes.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
KLRS
CIK
1754068
Form type
DEF 14A
Filing date
Apr 12, 2021
Report date
May 25, 2021
Document
d139434ddef14a.htm
Size
987 KB